107,210 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by BLI Banque de Luxembourg Investments

BLI Banque de Luxembourg Investments bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 107,210 shares of the healthcare conglomerate's stock, valued at approximately $54,485,000. UnitedHealth Group accounts for about 1.5% of BLI Banque de Luxembourg Investments' holdings, making the stock its 20th biggest holding.

A number of other large investors also recently bought and sold shares of the business. Western Pacific Wealth Management LP grew its stake in shares of UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after buying an additional 19 shares during the last quarter. MCF Advisors LLC grew its stake in shares of UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after acquiring an additional 20 shares during the last quarter. Axiom Financial Strategies LLC boosted its stake in UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after purchasing an additional 20 shares in the last quarter. Richwood Investment Advisors LLC increased its stake in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares in the last quarter. Finally, 44 Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after buying an additional 21 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Raymond James reiterated a "strong-buy" rating and set a $540.00 target price (down from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Hsbc Global Res downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 22nd. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday. Finally, Truist Financial lowered their price target on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Four investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $596.86.

UnitedHealth Group Price Performance

UNH stock opened at $398.72 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market capitalization of $362.92 billion, a PE ratio of 25.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company's fifty day moving average price is $495.85 and its 200-day moving average price is $528.45. UnitedHealth Group Incorporated has a one year low of $393.11 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. UnitedHealth Group's dividend payout ratio is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.